|
1
|
Podolsky DK: Inflammatory bowel disease. N
Engl J Med. 347:417–429. 2002. View Article : Google Scholar
|
|
2
|
Halfvarson J, Bodin L, Tysk C, Lindberg E
and Järnerot G: Inflammatory bowel disease in a Swedish twin
cohort: a long-term follow-up of concordance and clinical
characteristics. Gastroenterology. 124:1767–1773. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thompson NP, Driscoll R, Pounder RE and
Wakefield AJ: Genetics versus environment in inflammatory bowel
disease: results of a British twin study. BMJ. 312:95–96. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tysk C, Lindberg E, Järnerot G and
Flodérus-Myrhed B: Ulcerative colitis and Crohn’s disease in an
unselected population of monozygotic and dizygotic twins. A study
of heritability and the influence of smoking. Gut. 29:990–996.
1988.
|
|
5
|
Yamazaki K, McGovern D, Ragoussis J,
Paolucci M, Butler H, Jewell D, Cardon L, Takazoe M, Tanaka T,
Ichimori T, Saito S, Sekine A, et al: Single nucleotide
polymorphisms in TNFSF15 confer susceptibility to Crohn’s disease.
Hum Mol Genet. 14:3499–3506. 2005.
|
|
6
|
Duerr RH, Taylor KD, Brant SR, Rioux JD,
Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M,
Griffiths A, Dassopoulos T, Bitton A, et al: A genome-wide
association study identifies IL23R as an inflammatory bowel
disease gene. Science. 314:1461–1463. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hampe J, Franke A, Rosenstiel P, Till A,
Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J,
Günther S, Prescott NJ, et al: A genome-wide association scan of
nonsynonymous SNPs identifies a susceptibility variant for Crohn
disease in ATG16L1. Nat Genet. 39:207–211. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rioux JD, Xavier RJ, Taylor KD, Silverberg
MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW,
Shugart YY, Griffiths AM, et al: Genome-wide association study
identifies new susceptibility loci for Crohn disease and implicates
autophagy in disease pathogenesis. Nat Genet. 39:596–604. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wellcome Trust Case Control Consortium.
Genome-wide association study of 14,000 cases of seven common
diseases and 3,000 shared controls. Nature. 447:661–678. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Parkes M, Barrett JC, Prescott NJ,
Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER,
Cummings FR, Soars D, Drummond H, Lees CW, et al: Sequence variants
in the autophagy gene IRGM and multiple other replicating
loci contribute to Crohn’s disease susceptibility. Nat Genet.
39:830–832. 2007.PubMed/NCBI
|
|
11
|
Barrett JC, Hansoul S, Nicolae DL, Cho JH,
Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM,
Bitton A, Dassopoulos T, et al: Genome-wide association defines
more than 30 distinct susceptibility loci for Crohn’s disease. Nat
Genet. 40:955–962. 2008.PubMed/NCBI
|
|
12
|
Petronis A and Petroniene R: Epigenetics
of inflammatory bowel disease. Gut. 47:302–306. 2000. View Article : Google Scholar
|
|
13
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Robertson KD: DNA methylation and human
disease. Nat Rev Genet. 6:597–610. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maeda O, Ando T, Watanabe O, Ishiguro K,
Ohmiya N, Niwa Y and Goto H: DNA hypermethylation in colorectal
neoplasms and inflammatory bowel disease: a mini review.
Inflammopharmacology. 14:204–206. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tahara T, Shibata T, Nakamura M, Yamashita
H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Nakagawa Y,
Fujita H, Nagasaka M, et al: Effect of MDR1 gene promoter
methylation in patients with ulcerative colitis. Int J Mol Med.
23:521–527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yi JM, Dhir M, Guzzetta AA,
Iacobuzio-Donahue CA, Heo K, Yang KM, Suzuki H, Toyota M, Kim HM
and Ahuja N: DNA methylation biomarker candidates for early
detection of colon cancer. Tumour Biol. 33:363–372. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim TO, Park J, Kang MJ, Lee SH, Jee SR,
Ryu DY, Yang K and Yi JM: DNA hypermethylation of a selective gene
panel as a risk marker for colon cancer in patients with ulcerative
colitis. Int J Mol Med. 31:1255–1261. 2013.PubMed/NCBI
|
|
19
|
Laird PW: The power and the promise of DNA
methylation markers. Nat Rev Cancer. 3:253–266. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Widschwendter M and Menon U: Circulating
methylated DNA: a new generation of tumor markers. Clin Cancer Res.
12:7205–7208. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wallner M, Herbst A, Behrens A, Crispin A,
Stieber P, Göke B, Lamerz R and Kolligs FT: Methylation of serum
DNA is an independent prognostic marker in colorectal cancer. Clin
Cancer Res. 12:7347–7352. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Esteller M, Sanchez-Cespedes M, Rosell R,
Sidransky D, Baylin SB and Herman JG: Detection of aberrant
promoter hypermethylation of tumor suppressor genes in serum DNA
from non-small cell lung cancer patients. Cancer Res. 59:67–70.
1999.PubMed/NCBI
|
|
23
|
deVos T, Tetzner R, Model F, Weiss G,
Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C,
Habermann JK, Fleshner PR, Oubre BM, et al: Circulating methylated
SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin
Chem. 55:1337–1346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang SK, Yun S, Kim JH, Park JY, Kim HY,
Kim YH, Chang DK, Kim JS, Song IS, Park JB, Park ER, Kim KJ, et al:
Epidemiology of inflammatory bowel disease in the Songpa-Kangdong
district, Seoul, Korea, 1986–2005: a KASID study. Inflamm Bowel
Dis. 14:542–549. 2008.
|
|
25
|
Loftus EV Jr, Silverstein MD, Sandborn WJ,
Tremaine WJ, Harmsen WS and Zinsmeister AR: Crohn’s disease in
Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and
survival. Gastroenterology. 114:1161–1168. 1998.
|
|
26
|
Lee YJ, Yang SK, Byeon JS, Myung SJ, Chang
HS, Hong SS, Kim KJ, Lee GH, Jung HY, Hong WS, Kim JH, Min YI, et
al: Analysis of colonoscopic findings in the differential diagnosis
between intestinal tuberculosis and Crohn’s disease. Endoscopy.
38:592–597. 2006.
|
|
27
|
Brentnall TA, Crispin DA, Rabinovitch PS,
Haggitt RC, Rubin CE, Stevens AC and Burmer GC: Mutations in the
p53 gene: an early marker of neoplastic progression in ulcerative
colitis. Gastroenterology. 107:369–378. 1994.PubMed/NCBI
|
|
28
|
Schuebel KE, Chen W, Cope L, Glöckner SC,
Suzuki H, Yi JM, Chan TA, Van Neste L, Van Criekinge W, van den
Bosch S, van Engeland M, Ting AH, et al: Comparing the DNA
hypermethylome with gene mutations in human colorectal cancer. PLoS
Genet. 3:1709–1723. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sánchez-Alvarez M, Goldstrohm AC,
Garcia-Blanco MA and Suñé C: Human transcription elongation factor
CA150 localizes to splicing factor-rich nuclear speckles and
assembles transcription and splicing components into complexes
through its amino and carboxyl regions. Mol Cell Biol.
26:4998–5014. 2006.
|
